✦ LIBER ✦

Glycoprotein IIb/IIIa inhibitors and low-molecular-weight heparins: A combined role in coronary interventions?

✍ Scribed by EDWARD T. A. Fry

Book ID: 112065717
Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 398 KB
Volume: 24
Category: Article
ISSN: 0160-9289
DOI: 10.1002/clc.4960241304

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and effectiveness of combined low

Safety and effectiveness of combined low molecular weight heparin and glycoprotein IIb/IIIa inhibitors

✍ David Kovar; John G Canto; William J Rogers 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Use of Low Molecular Weight Heparins and

Use of Low Molecular Weight Heparins and Glycoprotein IIb/IIIa Inhibitors in Patients with Chronic Kidney Disease

✍ Mark A. Perazella; Ari Mosenkis; Jeffrey S. Berns 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

Applications of monitoring platelet glyc

Applications of monitoring platelet glycoprotein IIb/IIIa antagonism and low molecular weight heparins in cardiovascular medicine

✍ David J Moliterno; Debabrata Mukherjee 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Pharmacokinetics and Pharmacodynamics of

Pharmacokinetics and Pharmacodynamics of Low-Molecular-Weight Heparins and Glycoprotein IIb/IIIa Receptor Antagonists in Renal Failure

✍ Brian S. Smith; Pritesh J. Gandhi 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 114 KB

Low-molecular-weight heparin vs. unfract

Low-molecular-weight heparin vs. unfractionated heparin in percutaneous coronary intervention: A combined analysis

✍ Maria Borentain; Gilles Montalescot; Anissa Bouzamondo; Rémi Choussat; Jean-Séba 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

## Abstract This meta‐analysis assessed the rates of the efficacy and safety endpoints with intravenous low‐molecular‐weight heparin (LMWH) compared with unfractionated heparin (UFH) in patients undergoing percutaneous coronary intervention (PCI). Subcutaneous LMWH has compared favorably with UFH,

Dosing considerations and monitoring of

Dosing considerations and monitoring of low molecular weight heparins and glycoprotein IIb/IIIa antagonists in patients with renal insufficiency

✍ Chidambaram Rammohan; Dan Fintel 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 251 KB